(Q44474837)

English

Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

Philippa Talmud

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

A M Abuzeid

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

E Hawe

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

S E Humphries

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

HIFMECH Study Group

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

168

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

283-288

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Platelet-activating factor acetylhydrolases in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Lipoprotein-Associated Phospholipase A 2 , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Infection and inflammation induce LDL oxidation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Plasma Platelet-activating Factor Acetylhydrolase Is a Secreted Phospholipase A2 with a Catalytic Triad

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900086-8

7 January 2021

Identifiers

10.1016/S0021-9150(03)00086-8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44474837&oldid=2025220771"